Jieji Xuanfei Chuyi granules in the treatment of COVID-19: A randomized, open-label, parallel-controlled clinical trial
JJXFCY has therapeutic effects in treating mild COVID-19 cases. It reduced the persistence of COVID-19 symptoms, improved outcomes, and reduced the risk of hospitalization or death in adults with COVID-19.
Authors
- Li Shi (ORCID: https://orcid.org/0009-0005-3809-7260)
- Yingzi Cui
- Zhiyu Tian (ORCID: https://orcid.org/0000-0002-5822-976X)
- Zhenghua Cao (ORCID: https://orcid.org/0009-0008-2827-9775)
- Feng Sun (ORCID: https://orcid.org/0000-0002-8413-5177)
- Huan Ding (ORCID: https://orcid.org/0000-0003-3894-3875)
- Shaodan Hu
Institutions
- Changchun University of Chinese Medicine (CN)
- The Affiliated Hospital to Changchun University of Chinese Medicine (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1097/md.0000000000041740
- Primary Topic
- Pharmacological Effects of Natural Compounds
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- State Administration of Traditional Chinese Medicine of the People's Republic of China